Etiology, clinical course and outcome of healthcare-associated bloodstream infections in patients with hematological malignancies: a retrospective study of 350 patients in a Finnish tertiary care hospital

References

• Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–1601.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Seifert H, Wenzel RP, et al. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003;36:1103–1110.
   PubMed Web of Science ®Google Scholar
• Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999;29:490–494.
   PubMed Web of Science ®Google Scholar
• Elting LS, Rubenstein EB, Rolston KV, et al. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997;25:247–259.
   PubMed Web of Science ®Google Scholar
• Ortega M, Rovira M, Almela M, et al. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol 2005;84:40–46.
   PubMed Web of Science ®Google Scholar
• Mikulska M, Del Bono V, Raiola AM, et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 2009;15:47–53.
   PubMed Web of Science ®Google Scholar
• Cattaneo C, Quaresmini G, Casari S, et al. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother 2008;61:721–728.
   PubMed Web of Science ®Google Scholar
• Mendes ET, Dulley F, Basso M, et al. Healthcare-associated infection in hematopoietic stem cell transplantation patients: risk factors and impact on outcome. Int J Infect Dis 2012;16:e424–428.
   PubMed Web of Science ®Google Scholar
• Official Statistics of Finland (OSF). Population Structure. Helsinki: Statistics Finland; 2011.[Internet] - [cited 2011 October]; Available from: http://www.stat.fi/til/vrm_en.html
   Google Scholar
• Lyytikainen O, Lumio J, Sarkkinen H, Kolho E, Kostiala A, Ruutu P, Hospital Infection Surveillance T. Nosocomial bloodstream infections in Finnish hospitals during 1999–2000. Clin Infect Dis 2002;35:e14–9.
   PubMed Web of Science ®Google Scholar
• Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.
   PubMed Web of Science ®Google Scholar
• Velasco E, Byington R, Martins CA, et al. Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center. Eur J Clin Microbiol Infect Dis 2003;22:137–143.
   PubMed Web of Science ®Google Scholar
• Syrjala H, Ohtonen P, Kinnunen U, et al., Finnish Leukemia Group. Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters. Eur J Clin Microbiol Infect Dis 2010;29:1211–1218.
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Spanu T, Caira M, et al. Factors associated with mortality in bacteremic patients with hematologic malignancies. Diagnost Microbiol Infect Dis 2009;64:320–326.
   PubMed Web of Science ®Google Scholar
• Norgaard M, Larsson H, Pedersen G, et al. Risk of bacteraemia and mortality in patients with haematological malignancies. Clin Microbiol Infect 2006;12:217–223.
   PubMed Web of Science ®Google Scholar
• Cattaneo C, Antoniazzi F, Casari S, et al.. Paeruginosa bloodstream infections among hematological patients: an old or new question? Ann Hematol 2012;91:1299–304.
   PubMed Web of Science ®Google Scholar
• Huoi C, Vanhems P, Nicolle MC, et al. Incidence of hospital-acquired pneumonia, bacteraemia and urinary tract infections in patients with haematological malignancies, 2004-2010: A surveillance-based study. PLoS ONE [Electronic Resource] 2013;8:e58121.
   PubMed Web of Science ®Google Scholar
• Madani TA. Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection 2000;28:367–373.
   PubMed Web of Science ®Google Scholar
• Viscoli C, Cometta A, Kern WV, et al.,International Antimicrobial Therapy Group of the European Organization for Research and Treatment of Cancer. Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients. Clin Microbiol Infect 2006;12:212–216.
   PubMed Web of Science ®Google Scholar
• Steinberg JP, Coffin SE. Improving the central line-associated bloodstream infection surveillance definition: a work in progress. Infect Control Hospital Epidemiol 2013;34:777–779.
   PubMed Web of Science ®Google Scholar
• Steinberg JP, Robichaux C, Tejedor SC, et al. Distribution of pathogens in central line-associated bloodstream infections among patients with and without neutropenia following chemotherapy: evidence for a proposed modification to the current surveillance definition. Infect Control Hospital Epidemiol 2013;34:171–175.
   PubMed Web of Science ®Google Scholar
• Dutcher K, Lederman ER, Brodine S, et al. Impact of the 2013 revised centers for disease control and prevention central line-associated bloodstream infection (CLABSI) surveillance definition on inpatient hospital CLABSI rates: is it enough? Infect Control Hospital Epidemiol 2013;34:999–1001.
   PubMed Web of Science ®Google Scholar
• Kjellander C, Bjorkholm M, Cherif H, et al. Hematological: low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study. Eur J Haematol 2012;88:422–430.
   PubMed Web of Science ®Google Scholar
• Rahikka P, Syrjanen J, Vuento R, et al. Methicillin-resistant staphylococcus aureus (MRSA) bacteraemia in Tampere University Hospital: case-control study, Finland October 2002 to January 2010. Euro Surveillance:Eur Communicable Dis Bull 2011;16.
   Google Scholar
• [Anonymous]. Antimicrobial resistance in Finland – Finres 2013 data, Finnish Study Group for antimicrobial resistance, National Institute for Health and Welfare 2013;35/2014.
   Google Scholar
• Castanheira M, Deshpande LM, Costello A, et al. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible P. aeruginosa collected during 2009-11 in 14 European and Mediterranean countries. J Antimicrob Chemother 2014;69:1804–1814.
   PubMed Web of Science ®Google Scholar
• Carmeli Y, Troillet N, Eliopoulos GM, et al. Emergence of antibiotic-resistant P. aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrobial Agents Chemother 1999;43:1379–1382.
   PubMed Web of Science ®Google Scholar
• Flowers CR, Seidenfeld J, Bow EJ, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2013;31:794–810.
   PubMed Web of Science ®Google Scholar
• Mikulska M, Del Bono V, Bruzzi P, et al. Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Infection 2012;40:271–278.
   PubMed Web of Science ®Google Scholar